Literature DB >> 27989830

Hydrogel based approaches for cardiac tissue engineering.

Laura Saludas1, Simon Pascual-Gil1, Felipe Prósper2, Elisa Garbayo3, María Blanco-Prieto4.   

Abstract

Heart failure still represents the leading cause of death worldwide. Novel strategies using stem cells and growth factors have been investigated for effective cardiac tissue regeneration and heart function recovery. However, some major challenges limit their translation to the clinic. Recently, biomaterials have emerged as a promising approach to improve delivery and viability of therapeutic cells and proteins for the regeneration of the damaged heart. In particular, hydrogels are considered one of the most promising vehicles. They can be administered through minimally invasive techniques while maintaining all the desirable characteristics of drug delivery systems. This review discusses recent advances made in the field of hydrogels for cardiac tissue regeneration in detail, focusing on the type of hydrogel (conventional, injectable, smart or nano- and micro-gel), the biomaterials used for its manufacture (natural, synthetic or hybrid) and the therapeutic agent encapsulated (stem cells or proteins). We expect that these novel hydrogel-based approaches will open up new possibilities in drug delivery and cell therapies.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biomaterial; Cell therapy; Hydrogel; Myocardial infarction; Protein therapy; Tissue engineering

Mesh:

Substances:

Year:  2016        PMID: 27989830     DOI: 10.1016/j.ijpharm.2016.10.061

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  24 in total

Review 1.  Current research trends and challenges in tissue engineering for mending broken hearts.

Authors:  Muhammad Qasim; Pala Arunkumar; Heather M Powell; Mahmood Khan
Journal:  Life Sci       Date:  2019-05-17       Impact factor: 5.037

2.  Development of a nanomedicine-loaded hydrogel for sustained delivery of an angiogenic growth factor to the ischaemic myocardium.

Authors:  Joanne O'Dwyer; Robert Murphy; Eimear B Dolan; Lenka Kovarova; Martin Pravda; Vladimir Velebny; Andreas Heise; Garry P Duffy; Sally Ann Cryan
Journal:  Drug Deliv Transl Res       Date:  2020-04       Impact factor: 4.617

Review 3.  Cardiac Organoids: A 3D Technology for Modeling Heart Development and Disease.

Authors:  Liyuan Zhu; Kui Liu; Qi Feng; Yingnan Liao
Journal:  Stem Cell Rev Rep       Date:  2022-05-08       Impact factor: 5.739

Review 4.  Current Trends in Biomedical Hydrogels: From Traditional Crosslinking to Plasma-Assisted Synthesis.

Authors:  Kathrina Lois M Taaca; Eloise I Prieto; Magdaleno R Vasquez
Journal:  Polymers (Basel)       Date:  2022-06-23       Impact factor: 4.967

Review 5.  Electrostatically Interactive Injectable Hydrogels for Drug Delivery.

Authors:  Ji Young Seo; Bong Lee; Tae Woong Kang; Jung Hyun Noh; Min Ju Kim; Yun Bae Ji; Hyeon Jin Ju; Byoung Hyun Min; Moon Suk Kim
Journal:  Tissue Eng Regen Med       Date:  2018-08-09       Impact factor: 4.169

Review 6.  Current Trends in Biomaterial Utilization for Cardiopulmonary System Regeneration.

Authors:  Adegbenro Omotuyi John Fakoya; David Adeiza Otohinoyi; Joshua Yusuf
Journal:  Stem Cells Int       Date:  2018-04-29       Impact factor: 5.443

Review 7.  Biodegradable Nanopolymers in Cardiac Tissue Engineering: From Concept Towards Nanomedicine.

Authors:  Saeed Mohammadi Nasr; Navid Rabiee; Sakineh Hajebi; Sepideh Ahmadi; Yousef Fatahi; Masoumehossadat Hosseini; Mojtaba Bagherzadeh; Amir Mohammad Ghadiri; Mohammad Rabiee; Vahid Jajarmi; Thomas J Webster
Journal:  Int J Nanomedicine       Date:  2020-06-18

Review 8.  Extracellular matrix-based biomaterials for cardiac regeneration and repair.

Authors:  Haotong Li; Minghui Bao; Yu Nie
Journal:  Heart Fail Rev       Date:  2021-09       Impact factor: 4.214

Review 9.  Cardiac Organoids to Model and Heal Heart Failure and Cardiomyopathies.

Authors:  Magali Seguret; Eva Vermersch; Charlène Jouve; Jean-Sébastien Hulot
Journal:  Biomedicines       Date:  2021-05-18

10.  The application of decellularized nucleus pulposus matrix/chitosan with transforming growth factor β3 for nucleus pulposus tissue engineering.

Authors:  Wenzhong Kuang; Chen Liu; Hongguang Xu
Journal:  Cytotechnology       Date:  2021-04-15       Impact factor: 2.040

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.